168 related articles for article (PubMed ID: 20570056)
61. Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection.
Paganelli M; Dallmeier K; Nyabi O; Scheers I; Kabamba B; Neyts J; Goubau P; Najimi M; Sokal EM
Hepatology; 2013 Jan; 57(1):59-69. PubMed ID: 22898823
[TBL] [Abstract][Full Text] [Related]
62. Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle.
Esser K; Lucifora J; Wettengel J; Singethan K; Glinzer A; Zernecke A; Protzer U
Antiviral Res; 2018 Mar; 151():4-7. PubMed ID: 29309795
[TBL] [Abstract][Full Text] [Related]
63. Hepatocytes transduced with human TERT gene acquire a prolonged lifespan in culture and retain permissiveness to hepatitis B virus.
Lv LP; Kong YL; Yan F; Ma P; Zhou XP; Zhang YY; Wen DQ; Yu XL; Zhang HY; Zhou H; Xu JB
Acta Virol; 2013; 57(3):305-11. PubMed ID: 24020756
[TBL] [Abstract][Full Text] [Related]
64. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
Li J; Tong S
Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
[TBL] [Abstract][Full Text] [Related]
65. Blocking peptides against HBV: preS1 protein selected from a phage display library.
Wang W; Liu Y; Zu X; Jin R; Xiao G
Biochem Biophys Res Commun; 2011 Sep; 412(4):633-7. PubMed ID: 21856287
[TBL] [Abstract][Full Text] [Related]
66. Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis.
Huang HC; Chen CC; Chang WC; Tao MH; Huang C
J Virol; 2012 Sep; 86(17):9443-53. PubMed ID: 22740403
[TBL] [Abstract][Full Text] [Related]
67. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes.
De Meyer S; Gong ZJ; Suwandhi W; van Pelt J; Soumillion A; Yap SH
J Viral Hepat; 1997 May; 4(3):145-53. PubMed ID: 9181523
[TBL] [Abstract][Full Text] [Related]
68. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.
Schulze A; Gripon P; Urban S
Hepatology; 2007 Dec; 46(6):1759-68. PubMed ID: 18046710
[TBL] [Abstract][Full Text] [Related]
69. Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes.
Zhang Z; Zehnder B; Damrau C; Urban S
FEBS Lett; 2016 Jul; 590(13):1915-26. PubMed ID: 27149321
[TBL] [Abstract][Full Text] [Related]
70. HBV culture and infectious systems.
Hayes CN; Chayama K
Hepatol Int; 2016 Jul; 10(4):559-66. PubMed ID: 26935052
[TBL] [Abstract][Full Text] [Related]
71. An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus.
Kim DH; Ni Y; Lee SH; Urban S; Han KH
BMB Rep; 2008 Sep; 41(9):640-4. PubMed ID: 18823587
[TBL] [Abstract][Full Text] [Related]
72. A function essential to viral entry underlies the hepatitis B virus "a" determinant.
Salisse J; Sureau C
J Virol; 2009 Sep; 83(18):9321-8. PubMed ID: 19570861
[TBL] [Abstract][Full Text] [Related]
73. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.
Glebe D; Aliakbari M; Krass P; Knoop EV; Valerius KP; Gerlich WH
J Virol; 2003 Sep; 77(17):9511-21. PubMed ID: 12915565
[TBL] [Abstract][Full Text] [Related]
74. Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.
Blanchet M; Sureau C; Labonté P
Antiviral Res; 2014 Jun; 106():111-5. PubMed ID: 24717262
[TBL] [Abstract][Full Text] [Related]
75. Selection of HBV preS1-binding penta-peptides by phage display.
He Y; Ye X; Tiollais P; Zhang J; Zhang J; Liu J; Xie Y
Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):691-8. PubMed ID: 24966187
[TBL] [Abstract][Full Text] [Related]
76. Deciphering the mystery of hepatitis B virus receptors: A historical perspective.
Rehman Z; Fahim A; Sadia H
Virusdisease; 2015 Sep; 26(3):97-104. PubMed ID: 26396975
[TBL] [Abstract][Full Text] [Related]
77. HBV Slow Maturation Process Leads to Infection.
Watashi K
Trends Microbiol; 2016 Aug; 24(8):597-599. PubMed ID: 27345260
[TBL] [Abstract][Full Text] [Related]
78. Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.
Liu Q; Somiya M; Kuroda S
World J Gastroenterol; 2016 Oct; 22(38):8489-8496. PubMed ID: 27784961
[TBL] [Abstract][Full Text] [Related]
79. Ferritin light chain and squamous cell carcinoma antigen 1 are coreceptors for cellular attachment and entry of hepatitis B virus.
Hao Z; Zheng L; Kluwe L; Huang W
Int J Nanomedicine; 2012; 7():827-34. PubMed ID: 22359459
[TBL] [Abstract][Full Text] [Related]
80. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes.
Yan R; Zhang Y; Cai D; Liu Y; Cuconati A; Guo H
PLoS One; 2015; 10(6):e0129889. PubMed ID: 26070202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
